Elevance Health (ELV) stock
Last close $390.16 on 2026-11-19 (-2.66%) · Sector: Healthcare
Elevance Health is an American health insurance company, formerly known as Anthem, Inc. It makes most of its money by collecting premiums from employers, individuals, and government health programs, then paying for the medical care its members use.
Elevance's sales keep growing slowly, with revenue up 3.6% over the past year, but profit margins are thin and have shrunk recently. The stock returned 24.3% over the past year, beating the S&P 500's 9.7% gain. Shares are 13.4% below their 52-week high and sit 6.3% under their 50-day average, and insiders sold about $5.2 million of stock over the last 90 days while the CEO bought $1.0 million in July.
Key numbers
- Market cap: $84.9B
- Revenue (last 12 months): $201.83B
- Revenue growth: +3.6%
- Gross margin: 89.0%
- Operating margin: 2.7%
- P/E: 16.6
- P/S: 0.4
- Debt to equity: 0.68
- Current ratio: 1.47
Quality score
Overall 27/100 · growth 33 · profitability 23 · financial health 45 · value 8
Performance and risk
1-year return +24.3% vs S&P 500 +9.7% · volatility 35.8% (S&P 500 13.8%) · largest drop -26.5% · beta 0.30
Stock move the day after earnings
- 2026-01-28: +5.9%
- 2026-04-22: +0.0%
- 2026-07-15: -8.5%
- 2026-10-21: -1.4%
Insider trades (12 months)
Bought $2.3M · sold $7.0M
ELV stock research · ELV options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.